These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

574 related items for PubMed ID: 8643444

  • 1. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.
    Przedborski S, Jackson-Lewis V, Yokoyama R, Shibata T, Dawson VL, Dawson TM.
    Proc Natl Acad Sci U S A; 1996 May 14; 93(10):4565-71. PubMed ID: 8643444
    [Abstract] [Full Text] [Related]

  • 2. Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study.
    Watanabe H, Muramatsu Y, Kurosaki R, Michimata M, Matsubara M, Imai Y, Araki T.
    Eur Neuropsychopharmacol; 2004 Mar 14; 14(2):93-104. PubMed ID: 15013024
    [Abstract] [Full Text] [Related]

  • 3. Role of nitric oxide synthase against MPTP neurotoxicity in mice.
    Kurosaki R, Muramatsu Y, Michimata M, Matsubara M, Kato H, Imai Y, Itoyama Y, Araki T.
    Neurol Res; 2002 Oct 14; 24(7):655-62. PubMed ID: 12392201
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Methamphetamine- and 1-methyl-4-phenyl- 1,2,3, 6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice.
    Itzhak Y, Martin JL, Ali SF.
    Synapse; 1999 Dec 15; 34(4):305-12. PubMed ID: 10529724
    [Abstract] [Full Text] [Related]

  • 11. Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice.
    Yokoyama H, Takagi S, Watanabe Y, Kato H, Araki T.
    J Neural Transm (Vienna); 2008 Jun 15; 115(6):831-42. PubMed ID: 18235988
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/bl and CD-1 mice.
    Muthane U, Ramsay KA, Jiang H, Jackson-Lewis V, Donaldson D, Fernando S, Ferreira M, Przedborski S.
    Exp Neurol; 1994 Apr 15; 126(2):195-204. PubMed ID: 7925820
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of neuronal nitric oxide synthase protects against MPTP toxicity.
    Klivenyi P, Andreassen OA, Ferrante RJ, Lancelot E, Reif D, Beal MF.
    Neuroreport; 2000 Apr 27; 11(6):1265-8. PubMed ID: 10817604
    [Abstract] [Full Text] [Related]

  • 16. Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease.
    Breidert T, Callebert J, Heneka MT, Landreth G, Launay JM, Hirsch EC.
    J Neurochem; 2002 Aug 27; 82(3):615-24. PubMed ID: 12153485
    [Abstract] [Full Text] [Related]

  • 17. Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease.
    Watanabe Y, Kato H, Araki T.
    Metab Brain Dis; 2008 Mar 27; 23(1):51-69. PubMed ID: 18030609
    [Abstract] [Full Text] [Related]

  • 18. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS, Brown EM, Miller MS, Carswell S.
    J Pharmacol Exp Ther; 1999 Feb 27; 288(2):421-7. PubMed ID: 9918541
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.